You need Adobe Acrobat Reader to be able to view
the PDF files. You may already have it installed.
If not you can download it from the Adobe
website
here
or by clicking on the graphic.
The Influence of
glomerülar fIltratIon rate In outcomes of drug-elutIng stents ImplantatIon
In patIents wIth coronary artery dIsease and chronIc kIdney dIsease
Batyraliev T, Shulzhenko L, Arystanova
A, Pershukov I, Fettser D, Sidorenko B, Avşar Ö, Sadykov T, Belenkov Y.
The role of reduce of glomerular
filtration rate in outcomes of drug-eluting stents implantation in
patients with ischemic heart disease and chronic kidney disease.
In this study were
consecutively included 432 patients who in 2005 have undergone percutaneous
coronary intervention (PCI) with one or more drug - eluting stent
implantation. Included in the study patients were divided into 3
groups by the glomerular filtration rate (GFR): group 1 - 271 patients
with GFR > 60 ml/min/1,73m2, group 2 - 132 patients with GFR between 30
and 60 ml/min/1,73m2, and group 3 consisted of 29 patients with GFR
less than 30 ml/min/1,73m2. In all the patients only used contrast agent
Iodixanol, and the prevention of contrast-induced nephropathy (CIN) was
performed without fail. The immediate success of PCI was high and
comparable in all groups. The frequency of CIN was significantly higher in
groups 2 and 3 (6,8% and 17,2% against 0,7% in group 1, p <0,001). Within 12
months of observation the frequency of restenosis was higher in groups 2 and
3: 15,9% and 27,6% against 6,6% in group 1 (p <0,001). Reduced GFR was a
predictor of long-term up to 3 years mortality in patients with CKD, where
as for group 2 compared with group 1 the relative risk (RR) of death =
1.77 (95% CI 1,19 ÷ 3,74; p = 0.001), and for group 3 compared with group
1 RR of death = 3.69 (95% CI 1,58 ÷ 6,87; p = 0.001). In addition decreased
GFR was a predictor of nonfatal MI within 3 years: for group 2 vs. group 1
RR = 1.69 (95% CI 1,12 ÷ 3,07; p = 0.009) and group 3 vs. group 1 RR = 3.44
(95% CI 1,37 ÷ 6,19; p = 0.001).
The study showed that the
initially reduced GFR after stenting increases the risk of CIN, leads to an
increase in the frequency of restenosis and repeated revascularization up
to 12 months, and is a predictor of long-term death and nonfatal MI up to 3
years.
Gümrükçüoğlu A.H, Akdağ S,
Şimşek H, Şahin M, Tuncer M.
We evaluated the
clinical, angiographic aspects and hospital mortality in
patients with acute ST-segment elevation myocardial
infarction (STEMI) undergoing primary percutaneous coronary
intervention (PCI).
The study
included 248 consecutive patients (172 males, 76 females;
mean age 59,3±11,6 years) who underwent PCI for STEMI within
twelve hours after the onset of symptoms. PCI (balloon
angioplasty and / or stent placement) was performed only
infarct related artery. The procedural success in acute
phase defined as stenos falling below 50% and TIMI III flow
in infract related artery.
Primary PCI
was done 248 patients with STEMI at 2010. The most frequent
risk factors for coronary artery disease were cigarette
smoking and hypertension. The most common anatomic
localization of STEMI was anterior. Success rate was 95.8%
for primary PCI. Mortality occurred in 15 (5,8%) patients
STEMI.
As a result,
primary PCI reperfusion therapy provides a significant
reduction in deaths when used with app-ropriate timing.
Better use of reperfusion strategies in national and
regional more efforts requirement.
Key Words:
Primary percutaneus coronary intervention, SE elevation
myocardial infarct
EchocardIographIc evaluatIon of left ventrIcular systolIc and
dIastolIc functIons wIth usIng a novel Index
Sürücü H, Okudan S,
Değirmenci A, Boz H, Ertürk M, Tatlı E.
We aim to investigate
the clinical significance of a new index that evaluates
systolic and diastolic functions together in left
ventricular diastolic dysfunction (LVDDF).
Cases were
divided into four groups according to their left
ventricular (LV) inflow and pulsed wave tissue Doppler
imaging (pw-TDI). Group 1 (n=112) represented normal
diastolic LV inflow while group 2 (n=128) represen-ted
impaired LV relaxation, group 3 (n=46) represented
pseudonormalization and group 4 (n= 15) represented
reversible restrictive LVDDF. We defined a new index (novel
index=Ea-Aa/Sa) by using the pw-TDI parameters taken from LV
basal-lateral annulus and subtracting late (Aa) velocity
from early (Ea) velocity and dividing it by systolic (Sa)
velocity. Among the index that evaluate systolic and
diastolic functions together, novel index and Tei index were
lower in group 1 (control group) compared to other groups.
However, while Tei index was not different among the
patients with LVDDF, novel index was different. Novel index
was lower in group 4 compared to group 1, 2, and 3 (respectively
p<0.001, p<0.001, p=0.025). And also, it was lower in group
3 compared to group 2 (p= 0.033). Another prominent
correlation was found between novel index and non-invasively
estimated pulmonary capillary wedge pressure (PCWP). Novel
index was negatively associated with PCWP alterations (correlation
rate= 43 %, p<0.001).
We
concluded that novel index may be useful a diagnostic tool
to detection of LVDDF. While Tei index was not different
among the patients with LVDDF, novel index was sensitive to
determine all of LVDDF.
Key Words:
Left ventricular systolic and diastolic functions,
Pulsed wave tissue Doppler, Novel index
EvaluatIon of vIable
myocardIum at rIsk: Current Status
Karan A, Aras D, Topaloğlu
S, Korkmaz Ş.
The frequency of ischemic heart
failure is increasing in developed and developing countries. Patients suffe-ring
from this disease have poor prognosis despite recent advances in several
therapies. It is showed that revascula-rization improves clinical outcomes
in these patients with viable myocardium. In contrast patients without
viable tissue do not benefit from revascularization. Therefore assesment of
myocardial viability is very important for a selection of candidates for
revascularization. Several modalities have been developed to evaluate viable
and nonviable myocardium. In this review, current status and future
expectations in these techniques and their value for the prediction of left
ventricular regional and global function, in exercise capacity and long-term
prognosis are discussed.
A case of
ruptured aneurysm of gIant sInus valsalva
Akar Bayram N, Baştuğ S, Sarı C,
Durmaz T, Keles T, Hıdıroğlu M, Erdoğan Ş.K, Bozkurt E.
Rupture
aneurysms of sinus valsalva are relatively rare lesions and
usually may cause manifestations of prompt onset. In this
case rupture aneurysm of sinus valsalva is diagnosed with
echocardiography. We presented a 29 years old Afghan man
with effort dyspnea, fatigue, shortness of breath and chest
pain for ten years.
PERCUTANEOUS INTERVENTION for subklavIan artery stenosIs: A case
report
Orçun S, Klılıç H, Akdemir R.
We report a case of
subclavian artery stenosis treated with percutaneous
angioplasty. A 35-year-old woman with hypertension presented
with different blood pressure in each arm. Angiography
showed severe stenosis (%99) of the left subclavian artery
proximal.
Stenotic
lesion was crossed by using a 0.014 inch 260 cm long
guidewire. The 8x40mm stent was placed over the lesion.
Control angiography shown that dissection of the left
subclavian artery before the lesion. After 8x40mm second
stent was placed over the dissection. Control angiographic
study depicted opening of the segment which had dissection
and good arterial flow toward the left subclavian and
vertebral artery. However, left internal mamarian artery was
occluded after placed of second stent. Patient had a little
chest pain due to LIMA occlusion. Although it is not an
important problem with the exception of patient will undergo
coronary bypass surgery in the future, it was bitter for us
that patient had chest pain after the intervention. LIMA
should been prevent if dissection occur during the procedure.
FONDAPARINUX FOR THE THERAPY of a patIent wIth heparIn-INDUCED
THROMBOCYTOPENIA durIng admInIstratIon of unfractIonated heparIn
due to transvenous pacIng: A case report
Karan A, Tuna Başyiğit F,
Malçok Gürel Ö, Topaloğlu S, Aras D,
Two distinct types of heparin-induced
thrombocytopenia (HIT) have been defined. Type I HIT is a
non-immunemediated side effect. In contrast type II HIT is
an immune-mediated life-threatening complication. Direct
thrombin inhibitors such as lepirudin and argatroban
approved by FDA for treating patients with HIT have been
studied. Although fondaparinux-a selective, synthetic factor
Xa inhibitor- lacks FDA approval for his indication, case
reports and series published up to date contribute to
growing evidence about it. In this case report, we
represented a 77 year-old man with atrioventricular block
who had been developed HIT in the course of unfractionated
heparin infusion for transient pacemaker and aimed to review
current status about the usage of fondaparinux in this
patients.